Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Precision omic portrait deciphers the epigenetic variable during cellular identity reshaping of metastatic head and neck squamous cell carcinoma.

Science bulletin·2026
Same author

Identification of an NNK-Associated Gene Signature and Tumor Microenvironmental Features in Head and Neck Squamous Cell Carcinoma.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2026
Same author

Editorial: Advancements in head and neck tumor treatment strategy driven by the perspective of precision oncology.

Frontiers in genetics·2026
Same author

Organoids glimpse: the nexus for diverse tumor heterogeneity.

Frontiers in cell and developmental biology·2026
Same author

Single-Cell Dissection of Malignant Cell Heterogeneity Reveals Functional Programs and Clinically Relevant Subtypes in Head and Neck Squamous Cell Carcinoma.

IUBMB life·2026
Same author

Gender differences in the long-term impact of early-life exposure to war on physical and mental health: Evidence from China.

SSM - population health·2026

相关实验视频

Updated: Jun 28, 2025

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
06:32

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Published on: January 9, 2019

7.9K

根据路径丰富评估识别分散性质瘤亚型

Qiushi Feng1,2,3, Zehua Dong1,2,3, Rongfang Nie1,2,3

  • 1Biomedical Informatics Research Lab, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, 211198, China.

Interdisciplinary sciences, computational life sciences
|April 18, 2024
PubMed
概括

我们通过分析瘤微环境路径,确定了三种新的质瘤亚型. 通过神经丰富的质瘤显示出更好的生存率,与带层丰富的类型不同,为精确的质瘤管理提供了新的见解.

关键词:
基因组不稳定性 基因组不稳定性质瘤是一种质瘤.神经通道的神经通道路径丰富方式分类为子类型.瘤微环境是一个微环境.

更多相关视频

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
09:17

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

Published on: September 13, 2022

2.3K
Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
05:45

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

9.6K

相关实验视频

Last Updated: Jun 28, 2025

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
06:32

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Published on: January 9, 2019

7.9K
Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
09:17

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

Published on: September 13, 2022

2.3K
Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
05:45

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

9.6K

科学领域:

  • 在瘤学瘤学.
  • 分子生物学分子生物学
  • 生物信息学是一种生物信息学.

背景情况:

  • 质瘤在分子,组织学和微环境特征方面表现出显著的异质性.
  • 目前缺乏综合瘤微环境 (TME) 组件的综合分类.

研究的目的:

  • 基于集成的TME通路签名来对扩散性质瘤进行分类.
  • 发现具有独特生物和临床特征的新型质瘤亚型.

主要方法:

  • 在三个独立的质瘤数据集 (TCGA-质瘤,CGGA325,CGGA301) 中,利用了17个通路丰富得分的共识聚类 (免疫,树皮,DNA修复,神经系统).

主要成果:

  • 鉴定出三种一致的亚型:增强肌体 (Str-G),增强神经 (Ner-G) 和混合 (Mix-G).
  • Ner-G亚型表现出较低的免疫透率,树突含量,突变负担和较高的瘤纯度,神经元丰富和改善的生存率,IDH1和CIC突变的比例更高.
  • Str-G亚型表现出与Ner-G相反的特征.

结论:

  • 这种新的分类为结质瘤生物学提供了新的见解,突出了神经元,免疫和肌层成分对瘤行为的差异性影响.
  • 神经元的丰富性与临床结果有积极的相关性,而免疫和 stromal 细胞的丰富性则对它们产生负面影响.
  • 这种分类为质瘤患者的精确管理策略提供了潜力.